2023-09-012024-08-312024-08-31false08168844FOOTPRINTS SURGERY LIMITED2025-05-1486220falseiso4217:GBPxbrli:pure081688442023-09-01081688442024-08-31081688442023-09-012024-08-31081688442022-09-01081688442023-08-31081688442022-09-012023-08-3108168844bus:SmallEntities2023-09-012024-08-3108168844bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3108168844bus:FullAccounts2023-09-012024-08-3108168844bus:PrivateLimitedCompanyLtd2023-09-012024-08-3108168844core:WithinOneYear2024-08-3108168844core:AfterOneYear2024-08-3108168844core:WithinOneYear2023-08-3108168844core:AfterOneYear2023-08-3108168844core:ShareCapital2024-08-3108168844core:SharePremium2024-08-3108168844core:RevaluationReserve2024-08-3108168844core:OtherReservesSubtotal2024-08-3108168844core:RetainedEarningsAccumulatedLosses2024-08-3108168844core:ShareCapital2023-08-3108168844core:SharePremium2023-08-3108168844core:RevaluationReserve2023-08-3108168844core:OtherReservesSubtotal2023-08-3108168844core:RetainedEarningsAccumulatedLosses2023-08-3108168844core:LandBuildings2024-08-3108168844core:PlantMachinery2024-08-3108168844core:Vehicles2024-08-3108168844core:FurnitureFittings2024-08-3108168844core:OfficeEquipment2024-08-3108168844core:NetGoodwill2024-08-3108168844core:IntangibleAssetsOtherThanGoodwill2024-08-3108168844core:ListedExchangeTraded2024-08-3108168844core:UnlistedNon-exchangeTraded2024-08-3108168844core:LandBuildings2023-08-3108168844core:PlantMachinery2023-08-3108168844core:Vehicles2023-08-3108168844core:FurnitureFittings2023-08-3108168844core:OfficeEquipment2023-08-3108168844core:NetGoodwill2023-08-3108168844core:IntangibleAssetsOtherThanGoodwill2023-08-3108168844core:ListedExchangeTraded2023-08-3108168844core:UnlistedNon-exchangeTraded2023-08-3108168844core:LandBuildings2023-09-012024-08-3108168844core:PlantMachinery2023-09-012024-08-3108168844core:Vehicles2023-09-012024-08-3108168844core:FurnitureFittings2023-09-012024-08-3108168844core:OfficeEquipment2023-09-012024-08-3108168844core:NetGoodwill2023-09-012024-08-3108168844core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3108168844core:ListedExchangeTraded2023-09-012024-08-3108168844core:UnlistedNon-exchangeTraded2023-09-012024-08-3108168844core:MoreThanFiveYears2023-09-012024-08-3108168844core:Non-currentFinancialInstruments2024-08-3108168844core:Non-currentFinancialInstruments2023-08-3108168844dpl:CostSales2023-09-012024-08-3108168844dpl:DistributionCosts2023-09-012024-08-3108168844core:LandBuildings2023-09-012024-08-3108168844core:PlantMachinery2023-09-012024-08-3108168844core:Vehicles2023-09-012024-08-3108168844core:FurnitureFittings2023-09-012024-08-3108168844core:OfficeEquipment2023-09-012024-08-3108168844dpl:AdministrativeExpenses2023-09-012024-08-3108168844core:NetGoodwill2023-09-012024-08-3108168844core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3108168844dpl:GroupUndertakings2023-09-012024-08-3108168844dpl:ParticipatingInterests2023-09-012024-08-3108168844dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3108168844core:ListedExchangeTraded2023-09-012024-08-3108168844dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3108168844core:UnlistedNon-exchangeTraded2023-09-012024-08-3108168844dpl:CostSales2022-09-012023-08-3108168844dpl:DistributionCosts2022-09-012023-08-3108168844core:LandBuildings2022-09-012023-08-3108168844core:PlantMachinery2022-09-012023-08-3108168844core:Vehicles2022-09-012023-08-3108168844core:FurnitureFittings2022-09-012023-08-3108168844core:OfficeEquipment2022-09-012023-08-3108168844dpl:AdministrativeExpenses2022-09-012023-08-3108168844core:NetGoodwill2022-09-012023-08-3108168844core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3108168844dpl:GroupUndertakings2022-09-012023-08-3108168844dpl:ParticipatingInterests2022-09-012023-08-3108168844dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3108168844core:ListedExchangeTraded2022-09-012023-08-3108168844dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3108168844core:UnlistedNon-exchangeTraded2022-09-012023-08-3108168844core:NetGoodwill2024-08-3108168844core:IntangibleAssetsOtherThanGoodwill2024-08-3108168844core:LandBuildings2024-08-3108168844core:PlantMachinery2024-08-3108168844core:Vehicles2024-08-3108168844core:FurnitureFittings2024-08-3108168844core:OfficeEquipment2024-08-3108168844core:AfterOneYear2024-08-3108168844core:WithinOneYear2024-08-3108168844core:ListedExchangeTraded2024-08-3108168844core:UnlistedNon-exchangeTraded2024-08-3108168844core:ShareCapital2024-08-3108168844core:SharePremium2024-08-3108168844core:RevaluationReserve2024-08-3108168844core:OtherReservesSubtotal2024-08-3108168844core:RetainedEarningsAccumulatedLosses2024-08-3108168844core:NetGoodwill2023-08-3108168844core:IntangibleAssetsOtherThanGoodwill2023-08-3108168844core:LandBuildings2023-08-3108168844core:PlantMachinery2023-08-3108168844core:Vehicles2023-08-3108168844core:FurnitureFittings2023-08-3108168844core:OfficeEquipment2023-08-3108168844core:AfterOneYear2023-08-3108168844core:WithinOneYear2023-08-3108168844core:ListedExchangeTraded2023-08-3108168844core:UnlistedNon-exchangeTraded2023-08-3108168844core:ShareCapital2023-08-3108168844core:SharePremium2023-08-3108168844core:RevaluationReserve2023-08-3108168844core:OtherReservesSubtotal2023-08-3108168844core:RetainedEarningsAccumulatedLosses2023-08-3108168844core:NetGoodwill2022-09-0108168844core:IntangibleAssetsOtherThanGoodwill2022-09-0108168844core:LandBuildings2022-09-0108168844core:PlantMachinery2022-09-0108168844core:Vehicles2022-09-0108168844core:FurnitureFittings2022-09-0108168844core:OfficeEquipment2022-09-0108168844core:AfterOneYear2022-09-0108168844core:WithinOneYear2022-09-0108168844core:ListedExchangeTraded2022-09-0108168844core:UnlistedNon-exchangeTraded2022-09-0108168844core:ShareCapital2022-09-0108168844core:SharePremium2022-09-0108168844core:RevaluationReserve2022-09-0108168844core:OtherReservesSubtotal2022-09-0108168844core:RetainedEarningsAccumulatedLosses2022-09-0108168844core:AfterOneYear2023-09-012024-08-3108168844core:WithinOneYear2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108168844core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3108168844core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3108168844core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3108168844core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3108168844core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3108168844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3108168844core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3108168844core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3108168844core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3108168844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3108168844core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3108168844bus:Director12023-09-012024-08-3108168844bus:Director22023-09-012024-08-3108168844core:FurnitureFittingsToolsEquipment2023-08-3108168844core:FurnitureFittingsToolsEquipment2023-09-012024-08-3108168844core:FurnitureFittingsToolsEquipment2024-08-31

FOOTPRINTS SURGERY LIMITED

Registered Number
08168844
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

FOOTPRINTS SURGERY LIMITED
Company Information
for the year from 1 September 2023 to 31 August 2024

Directors

GOHIL, Priti
SUTCLIFFE, Brian

Registered Address

2nd Floor Grove House
55 Lowlands Road
Harrow
HA1 3AW

Registered Number

08168844 (England and Wales)
FOOTPRINTS SURGERY LIMITED
Balance Sheet as at
31 August 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets44,8555,623
4,8555,623
Current assets
Stocks53,1123,500
Debtors64,1723,579
Cash at bank and on hand6,7287,688
14,01214,767
Creditors amounts falling due within one year7(13,769)(14,195)
Net current assets (liabilities)243572
Total assets less current liabilities5,0986,195
Creditors amounts falling due after one year8(1,500)(3,500)
Provisions for liabilities9(1,214)(1,406)
Net assets2,3841,289
Capital and reserves
Called up share capital100100
Profit and loss account2,2841,189
Shareholders' funds2,3841,289
The financial statements were approved and authorised for issue by the Board of Directors on 14 May 2025, and are signed on its behalf by:
GOHIL, Priti
Director
SUTCLIFFE, Brian
Director

Registered Company No. 08168844
FOOTPRINTS SURGERY LIMITED
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It is amortized to profit and loss account over its estimated economic life of 7 years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Fixtures and fittings25
Office Equipment25
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year22
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 September 23195,000195,000
At 31 August 24195,000195,000
Amortisation and impairment
At 01 September 23195,000195,000
At 31 August 24195,000195,000
Net book value
At 31 August 24--
At 31 August 23--
4.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 September 2318024,16524,345
Additions-710710
At 31 August 2418024,87525,055
Depreciation and impairment
At 01 September 2317018,55218,722
Charge for year21,4761,478
At 31 August 2417220,02820,200
Net book value
At 31 August 2484,8474,855
At 31 August 23105,6135,623
5.Stocks

2024

2023

££
Raw materials and consumables3,1123,500
Total3,1123,500
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables3,2292,636
Prepayments and accrued income943943
Total4,1723,579
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables4,7241,437
Bank borrowings and overdrafts2,0002,000
Taxation and social security4,7207,099
Other creditors1651,499
Accrued liabilities and deferred income2,1602,160
Total13,76914,195
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts1,5003,500
Total1,5003,500
9.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)1,2141,406
Total1,2141,406
10.Directors advances, credits and guarantees
Included in other creditors is an amount of £85(2023: £1,490 ) relates to the director's loan account B Sutcliffe. Included in other creditors is an amount of £81 (2023: £9 ) relates to the director's loan account P Gohil.